Case Study

Health media entrepreneur Sean Moloney

“Josh Meah & Company has been a real asset through and through in all of those ventures, dating back almost a decade. It has been an absolute pleasure working with Josh and his team — which is a true interdisciplinary team that not only is able to think differently, but they are able to execute and deliver on their promises.”

Sean Moloney
‍Health media entrepreneur

A former Director of Innovations at Pfizer, Sean Moloney created his own entity Dramatic Health that pioneered the patient health video and for two decades supported the largest pharmaceutical companies in the world. Sean’s interests and opportunities evolved to include his present role as the CEO of the 86-year old medical journal the Journal of Clinical Psychiatry and Psychiatrist.com, the CIO of The CME Institute, and Co-Founder of a new initiative that applies AR / XR media to clinical medical education.

JM&Co. supports all initiatives extensively, including at one time or another end to end sales and marketing services, consulting on fundraising and mergers and acquisitions, and various strategy and management consulting services.

Results are tracked as deliverables and determined Key Performance Indicators (KPIs). JM&Co. continues to achieve on all fronts.

Strategy

We partnered our marketing staff directly with their internal team. This helps manage seasonality and inventory while scaling ad campaigns. Daily optimization of the Google Shopping channel identifies winning and losing campaigns fast and facilitates cost-effective experimentation for campaign expansion.
‍
Custom audience modeling in Facebook combined with rapid multivariate testing of ad copies, graphics, and video delivered profitable campaigns at launch.

Regular strategic deep dives unearth cultural insights, new marketing angles, and alternative customer outreach methods (e.g. Bing, data-driven cataloging, selective print advertising). We draft and update their growth plan collaboratively, which includes a roadmap for greater scalability over the next 12-18 months.